Use of vaccines in the evaluation of presumed immunodeficiency.
نویسنده
چکیده
The assessment of the humoral immune response is a critical component in the evaluation of patients suspected of having a primary immune deficiency disease (PIDD).1 In fact, more than 50% of the patients with immune deficiency have some impairment in the ability to make specific antibodies and/or have a quantitative deficiency of antibodies. Although there are a number of laboratory tools that are helpful in the evaluation of patients suspected of having an antibody deficiency disorder, such as quantitative serum immunoglobulin analysis, analysis of lymphocyte subpopulations by flow cytometry, or even genetic diagnoses of single-gene mutations, the evaluation of a patient’s response to immunization with a vaccine and the production of specific antibodies are extremely important. The assessment of qualitative antibody responses is not only important in confirming a specific antibody immune deficiency but is also important in the decision-making process for using immunoglobulin replacement therapy.2,3 If on initial evaluation patients demonstrate a deficient quantitative antibody response, an antigen challenge or booster vaccine immunization with existing Food and Drug Administration (FDA)e approved vaccines can determine whether the patient has the ability to generate an adequate qualitative antibody response. In an effort to provide guidance in the evaluation of patients for a humoral PIDD, a working group of the Basic and Clinical Immunology Interest Section of the American Academy of Allergy, Asthma and Immunology (AAAAI) published a report in September 2012.4 This article discusses some of the topics related to the use and interpretation of vaccine responses in the evaluation of patients for a possible PIDD. Strategies and Evidence
منابع مشابه
Evaluation of Children with Complication of BCG Vaccination in North of Iran
Background: Although the efficacy of Bacillus Calmette-Guerin (BCG) vaccine in the prevention of tuberculosis has been noted consistently, the use of BCG vaccine is not without risk. In this study we aimed to evaluate immunologically, children with complication of BCG vaccination in North of Iran.Materials and Methods: This case-control study began in 30 Jan 2013 and was completed in 2 Jul 2015...
متن کاملEvaluation of Clinical and Laboratory Data in Patients with Recurrent Infections and Suspected Immunodeficiency
Background: Frequent infections is among the most frequent clinical dilemmas for primary care physicians. Immunodeficiency disorders are a heterogeneous group of illnesses that predispose patients to the recurrent infections, autoimmunity and malignancies. The aim of this study was to evaluate the clinical and laboratory data collected for the final diagnosis of patients referred with recurrent...
متن کاملO-2: Prospective Evaluation of the ThreatRelated to the Use of Seminal Fractions fromHepatitis C Virus-Infected Men in Assisted ReproductiveTechniques
Background: The risk of hepatitis C virus (HCV) transmission during assisted reproductive techniques (ARTs) is still disputed and no report concerning its prospective evaluation is available. The aim of this 4-year follow-up multicentre study that enrolled 86 HCV-serodiscordant couples was to determine whether a sperm-processing method was able to reduce levels of HCV in semen and the risk of H...
متن کاملPrimary immunodeficiency diseases (PIDs) is a diverse group of diseases, characterized by a defect in the immune system. These patients are susceptible to recurrent respiratory infections, gastrointestinal problems, autoimmune diseases, and malignancies. In most cases, patients with primary immunodeficiency disorders have genetic defects and are monogenic disorders that follow a simple Mendelia...
متن کاملEffect of the Commercial Mixed Live Newcastle Disease and Infectious Bronchitis Vaccines and the Use of Two Separate Vaccines Given Simultaneously on Systemic Antibody Responses
Background and Aims: The objective of this study was to investigate the effects of Newcastle Disease and Infectious Bronchitis vaccination programs in chickens. Materials and Methods and Results: In the present study, 225 day-old broiler chicks divided into 5 groups. The groups were submitted to vaccinations, except for the non-vaccinated control group. The chickens in the groups 1 were kept as...
متن کاملImmunogenicity evaluation of rBoNT/E nanovaccine after mucosal administration
Objective(s): The Botulism syndrome is caused by types A to G of botulinum neurotoxins. The binding domains of these neurotoxins are immunogenic and considered as appropriate candidate vaccines. Due to the low immunogenicity of recombinant vaccines, there have been many studies on the use of biocompatible carriers such as chitosan nanoparticles for the delivery of these vaccines. The aim of thi...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
دوره 111 3 شماره
صفحات -
تاریخ انتشار 2013